Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03055013 |
Recruitment Status :
Recruiting
First Posted : February 16, 2017
Last Update Posted : March 3, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Metastatic Renal Cell Carcinoma Sarcomatoid Renal Cell Carcinoma Stage II Renal Cell Cancer AJCC v7 Stage III Renal Cell Cancer AJCC v7 Unclassified Renal Cell Carcinoma | Procedure: Conventional Surgery Biological: Nivolumab Other: Patient Observation Other: Quality-of-Life Assessment Other: Questionnaire Administration | Phase 3 |


PRIMARY OBJECTIVE:
I. To compare recurrence-free survival (RFS) between patients with renal cell carcinoma randomly assigned to perioperative nivolumab in conjunction with radical or partial nephrectomy with patients randomized to surgery alone.
SECONDARY OBJECTIVES:
I. To evaluate for differences in recurrence-free survival associated with perioperative nivolumab compared to surgery alone among the subset of patients with clear cell histology.
II. To compare the overall survival between the two arms. III. To describe the safety and tolerability of perioperative nivolumab.
CORRELATIVE OBJECTIVES:
I. To correlate the primary tumor's expression of programmed cell death 1 ligand 1 (PD-L1) with outcome.
II. To correlate the expression of PD-L1 on tumor tissue at nephrectomy and recurrence with outcome.
III. To archive images for potential central confirmation of recurrence and for future correlative work with American College of Radiology Imaging Network (ACRIN), including markers predicting outcome or response.
IV. To prospectively collect tumor and biologic specimens (e.g., serum, peripheral blood mononuclear cells [PBMCs]) for future correlative studies.
V. To characterize the pharmacokinetics of nivolumab and explore exposure response relationships with respect to safety and efficacy.
VI. To characterize the immunogenicity of nivolumab.
QUALITY OF LIFE OBJECTIVE:
I. To evaluate differences in change from baseline in patient-reported symptoms and toxicities among patients randomized to treatment with nivolumab compared to surgery alone.
OTHER EXPLORATORY OBJECTIVES:
I. To explore descriptively the efficacy of treatment with nivolumab in patients with non-clear cell (including unclassified) histologies.
II. To characterize the effects of nivolumab on bone metabolism and bone density.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
ARM I: Patients receive nivolumab intravenously (IV) over 30 minutes on day 1. Treatment repeats every 14 days for 2 cycles. Patients then undergo partial or radical nephrectomy 7-28 days later. Patient then receive nivolumab over 30 IV on day 1. Treatment repeats every 14 days for 6 cycles, and then every 28 days for 6 cycles in the absence of disease progression or unacceptable toxicity.
Patients enrolled after Amendment 4 receive nivolumab IV over 30 minutes on day 1. Patients then undergo partial or radical nephrectomy 7-28 days later. Patients then receive nivolumab IV over 30 minutes on day 1. Treatment repeats every 4 weeks for up to 9 cycles in the absence of disease progression or unacceptable toxicity.
ARM II: Patients undergo partial or radical nephrectomy within 8 weeks after registration followed by observation.
After completion of study treatment, patients are followed up every 3 months for 2 years, every 6 months for 3 years, and every 12 months for 5 years.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 766 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC) |
Actual Study Start Date : | February 2, 2017 |
Estimated Primary Completion Date : | November 30, 2023 |
Estimated Study Completion Date : | November 30, 2023 |

Arm | Intervention/treatment |
---|---|
Experimental: Arm I (nivolumab, nephrectomy)
Patients receive nivolumab IV over 30 minutes on day 1. Treatment repeats every 14 days for 2 cycles. Patients then undergo partial or radical nephrectomy 7-28 days later. Patients then receive nivolumab over 30 IV on day 1. Treatment repeats every 14 days for 6 cycles, and then every 28 days for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients enrolled after Amendment 4 receive nivolumab IV over 30 minutes on day 1. Patients then undergo partial or radical nephrectomy 7-28 days later. Patient then receive nivolumab IV over 30 minutes on day 1. Treatment repeats every 4 weeks for up to 9 cycles in the absence of disease progression or unacceptable toxicity. |
Procedure: Conventional Surgery
Undergo nephrectomy Biological: Nivolumab Given IV
Other Names:
Other: Quality-of-Life Assessment Ancillary studies
Other Name: Quality of Life Assessment Other: Questionnaire Administration Ancillary studies |
Active Comparator: Arm II (nephrectomy)
Patients undergo partial or radical nephrectomy within 8 weeks after registration followed by observation.
|
Procedure: Conventional Surgery
Undergo nephrectomy Other: Patient Observation Undergo observation
Other Names:
Other: Quality-of-Life Assessment Ancillary studies
Other Name: Quality of Life Assessment Other: Questionnaire Administration Ancillary studies |
- Event-free survival (EFS) [ Time Frame: Time from randomization to disease recurrence or death from any cause, assessed up to 10 years ]Will be assessed among all randomized patients using a stratified log rank test, with nominal one-sided type I error of 2.5%. The type I error will be adjusted for interim analyses.
- Overall survival [ Time Frame: Time from randomization to death from any cause, assessed up to 10 years ]
- RFS among patients with clear cell cancer [ Time Frame: Up to 10 years ]The stratified logrank test will be used.
- Incidence of toxicity [ Time Frame: Up to 10 years ]Graded per Common Criteria for Adverse Events (CTCAE) version (v)4.0. (Starting April 1, 2018, Cancer Therapy Evaluation Program Adverse Event Reporting System [CTEP-AERS] reporting will use CTCAE v5). Adverse events will be described separately for patients treated on each arm to evaluate safety and tolerability.
- Primary tumor's expression of PD-L1 [ Time Frame: Baseline to up to 10 years ]The percentage of cells exhibiting cell-surface staining for PD-L1 will be scored. PD-L1 positivity will be defined per specimen by a 5% expression threshold. Additional analyses will assess the 1% and 10% threshold levels. Information with respect to the relative abundance and location (peritumoral/intratumoral) of immune cell (macrophage and lymphocyte) PD-L1 staining will be captured. The expression-by-treatment interaction will be tested using a proportional hazards model. McNemar's Test will be used to explore categorical changes within each treatment group.
- Expression of PD-L1 on tumor tissue at recurrence [ Time Frame: Up to 10 years ]
- Pharmacokinetic analysis of nivolumab [ Time Frame: On day 1 of cycles 1-3, 5, 7 and the first 2 follow-up visits ]Serum concentration analyses for nivolumab will be performed by validated bio-analytical methods for nivolumab.
- Change in patient-reported symptoms and toxicities [ Time Frame: Baseline to up to 10 years ]Using the National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy (NCCN/FACT) Kidney Symptom Index-19 (NFKSI-19) and items from the PRO-CTCAE pool of items measuring patient-reported toxicity. We will describe the severity, interference, and (as appropriate) frequency rates, along with response rates at each time point. Change in symptoms will be tested using a two-sided Wilcoxon rank sum test with Type I error of 3%. Change in physical function will be tested using a two-sided Wilcoxon rank sum test with Type I error of 1%. Changes in NFKSI-19 and PROMIS Physical Function scores from baseline to pre-nephrectomy among patients randomized to nivolumab and will be explored using a Wilcoxon signed rank test. Differences in scores post-nephrectomy between the arms will be described and tested using a Wilcoxon rank-sum test. Differences in the pattern of change over time in NFKSI-19 and PROMIS Physical Function scores will be examined using mixed effects models.
- Absolute T cell clonotype abundance [ Time Frame: Up to 10 years ]Will be determined by assessing the number of unique clonotypes identified. The data will be summarized descriptively and graphically.
- Change in T cell repertoire [ Time Frame: From diagnosis to on therapy or to time of recurrence, assessed up to 10 years ]Morisita's distance will be used as utilized by Cha and colleagues. Morisita's distance ranges from 0-1. Zero indicates minimal change in T cell repertoire (TCR) repertoire size (number of unique clonotypes) and 1 indicates maximal change after treatment.
- T cell receptor (TCR) diversity using change in repertoire size per patient [ Time Frame: Baseline to up to 10 years ]The top 25% of unique clonotypes will be identified by sorting for clone frequency. Fold change after recurrence will be measured and plotted on a logarithmic scale.
- Change in cytokine levels in patients randomized to the nivolumab arm [ Time Frame: Baseline to up to 10 years ]Differences in RFS between patients with and without robust CD8 infiltration will be explored. A Cox proportional hazards model will be used to test the interaction between treatment and cytokine changes.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- ELIGIBILITY CRITERIA FOR RANDOMIZATION:
- Patients with a renal mass consistent with a clinical stage >= T2Nx renal cell carcinoma (RCC) or TanyN+ RCC for which radical or partial nephrectomy is planned
-
Patients must have no clinical or radiological evidence of distant metastases (M0) unless the presumed M1 disease is planned to be resected/definitively treated (e.g., thermal ablation, stereotactic radiation) at the same time or within a 12 week window from the date of the initial procedure such that the patient is considered "no evidence of disease" (M1 NED)
- Liver, bone, or brain metastases are not permitted
- No more than 3 metastases are permitted and all must be able to be removed or definitively treated within 12 weeks of the primary tumor resection
-
If histological confirmation of RCC has not been done within 12 months prior to randomization, patient must be willing to undergo a core biopsy for this purpose if randomized to Arm A
-
NOTE: This histologic confirmation can be a (1) standard of care diagnostic biopsy or (2) a research biopsy or a planned metastasectomy. Tissue must be obtained with results available prior to the neoadjuvant dose
- Patients randomized to Arm A: core tumor biopsy must have demonstrated RCC of any histology, including sarcomatoid, unclassified, or "unknown histology" (if preoperative biopsy was uninformative) with exception below for non-diagnostic biopsies
- If the biopsy performed following randomization clearly demonstrates a benign condition, oncocytoma or a different type of cancer that is not RCC, the patient is not eligible and must come off study
- A non-diagnostic biopsy is considered a good faith effort and does not need to be repeated unless deemed clinically necessary by the treating investigator
-
-
Patient must not have any prior systemic or local anti-cancer therapy for the current RCC
- Patient must not have undergone a partial nephrectomy for the current RCC
- Patient must not have had a metastasectomy for the current RCC diagnosis unless performed to render patient NED (in addition to the planned nephrectomy) within 6 months of the current diagnosis
- Patient must not have received current or past antineoplastic systemic therapies for RCC: i.e., chemotherapy, hormonal therapy, immunotherapy, or standard or investigational agents for treatment of RCC
- Patient must not have received prior treatment with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CD137, or anti-CTLA-4 antibody, or any other antibody or drug specifically targeting T-cell co-stimulation or checkpoint pathways
- Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
-
Patient must not have a prior history of RCC that was treated with curative intent within the past 5 years
- Patients with a prior RCC that was treated > 5 years before, are eligible if the current tumor is consistent with a new primary in the opinion of the treating investigator
-
Patients with bilateral synchronous RCCs are eligible if they can be resected or definitively treated at the same time or within a 12 week window from time of initial nephrectomy (partial or radical) or procedure and maintain adequate residual renal function; the patient is not eligible if both kidneys are to be completely removed and subsequent hemodialysis will be required
-
Permitted forms of local therapy for second tumor:
- Partial or radical nephrectomy
- If tumor is =< 3 cm: thermal ablation (e.g., radiofrequency ablation, cryoablation or stereotactic radiosurgery)
-
-
Patients cannot have concurrent malignancies, with the following exceptions:
- Adequately treated basal cell or squamous cell skin cancer
-
In situ cervical cancer
- A history of superficial Ta urothelial cancer is permitted (as long as not currently undergoing treatment) whereas T1 or greater disease is excluded if < 3 years from diagnosis; concurrent persistent disease is not permitted
- Adequately treated stage I or II cancer from which the patient is currently in complete remission
- Any other cancer and stage from which the patient has been disease-free for at least 3 years prior to the time of randomization and as long as they are not receiving any current treatment (e.g. adjuvant or maintenance systemic or local therapy)
- Concurrent low risk prostate cancer on active surveillance
- Patient must not have active known or suspected autoimmune disease. The following autoimmune disorders are permitted: patients with vitiligo, type I diabetes mellitus, controlled/stable hypo or hyperthyroidism due to autoimmune or non-autoimmune conditions (hormone replacement is allowed), psoriasis not requiring systemic treatment, or other conditions not expected to recur
-
Patient must not have any ongoing condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalent) or other immunosuppressive medications with the exceptions outlined below; patient must not have received any treatment with other immunosuppressive agents within 14 days prior to the first dose of study drug with the following exceptions:
- Topical, ocular, intra-articular, intranasal, inhaled steroids and adrenal replacement steroid doses > 10 mg daily prednisone or the equivalent are permitted in the absence of active autoimmune disease
- A brief (less than 3 weeks) course of corticosteroids (any amount) for prophylaxis (for example: contrast dye allergy) or for treatment of non-autoimmune conditions (for example: nausea, delayed-type hypersensitivity reaction caused by a contact allergen) is permitted
- Patient must not have uncontrolled adrenal insufficiency
-
Patient must not have known evidence of chronic active liver disease or evidence of acute or chronic hepatitis B Virus (HBV) or hepatitis C (HCV); HBV and HCV testing must be completed within 8 weeks prior to randomization
- NOTE: If the patient has been treated and cured, and the HCV ribonucleic acid (RNA) is undetectable, the patient is eligible for this study
- Patient must not have any serious intercurrent illness, including ongoing or active infection requiring parenteral antibiotics
- Patient must not have known evidence of human immunodeficiency virus (HIV) infection, since the effects of nivolumab on anti-retroviral therapy have not been studied; HIV testing is only required if past or current history is suspected
- Patient must not have any known medical condition (e.g. a condition associated with uncontrolled diarrhea such as ulcerative colitis or acute diverticulitis) that, in the investigator's opinion, would increase the risk associated with study participation or interfere with the interpretation of safety results
- Patient must not have had any major surgery within 28 days prior to randomization
- Patient must not be currently enrolled in other clinical trials testing a therapeutic intervention
- Patient must not have any history of severe hypersensitivity to a monoclonal antibody
- Patient must have the ability to understand and the willingness to sign a written informed consent document
- Women must not be pregnant or breast-feeding, as the effects of nivolumab on the developing human fetus or in the nursing infant are unknown; all females of childbearing potential must have a blood test or urine study within 2 weeks prior to randomization to rule out pregnancy; a female of childbearing potential is defined as any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has achieved menarche at some point 2) has not undergone a hysterectomy or bilateral oophorectomy; or 3) has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
- Women of childbearing potential (WOCBP) and males who are sexually active with WOCBP must use accepted and effective method(s) of contraception, as described in the Informed Consent Form (ICF), or abstain from sexual intercourse for the duration of their participation in the study; women of childbearing potential must use adequate methods to avoid pregnancy for 5 months after the last dose of nivolumab; sexually active males must use adequate methods to avoid pregnancy for 7 months after the last dose of nivolumab
- White blood cells >= 2000/uL (within 8 weeks prior to randomization)
- Absolute neutrophil count (ANC) >= 1,500/mm^3 (within 8 weeks prior to randomization)
- Platelet count >= 100,000/mm^3 (within 8 weeks prior to randomization)
- Hemoglobin >= 9.0 g/dL (within 8 weeks prior to randomization)
- Serum creatinine =< 1.5 x upper limit of normal (ULN) or calculated creatinine clearance (CrCl) >= 40mL/min (within 8 weeks prior to randomization)
- Total bilirubin =< 1.5 x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < 3.0 x ULN) (within 8 weeks prior to randomization)
- Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 2.5 x ULN (within 8 weeks prior to randomization)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03055013


United States, Alabama | |
University of Alabama at Birmingham Cancer Center | Recruiting |
Birmingham, Alabama, United States, 35233 | |
Contact: Site Public Contact 205-934-0220 tmyrick@uab.edu | |
Principal Investigator: Arnab Basu | |
United States, Arizona | |
Cancer Center at Saint Joseph's | Suspended |
Phoenix, Arizona, United States, 85004 | |
Banner University Medical Center - Tucson | Recruiting |
Tucson, Arizona, United States, 85719 | |
Contact: Site Public Contact aselegue@email.arizona.edu | |
Principal Investigator: Benjamin R. Lee | |
University of Arizona Cancer Center-North Campus | Recruiting |
Tucson, Arizona, United States, 85719 | |
Contact: Site Public Contact 800-327-2873 | |
Principal Investigator: Benjamin R. Lee | |
United States, California | |
Kaiser Permanente-Anaheim | Recruiting |
Anaheim, California, United States, 92806 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Helen H. Moon | |
Sutter Auburn Faith Hospital | Suspended |
Auburn, California, United States, 95602 | |
AIS Cancer Center at San Joaquin Community Hospital | Suspended |
Bakersfield, California, United States, 93301 | |
Kaiser Permanente-Baldwin Park | Recruiting |
Baldwin Park, California, United States, 91706 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Helen H. Moon | |
Kaiser Permanente-Bellflower | Recruiting |
Bellflower, California, United States, 90706 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Helen H. Moon | |
Alta Bates Summit Medical Center-Herrick Campus | Recruiting |
Berkeley, California, United States, 94704 | |
Contact: Site Public Contact 415-209-2686 bernicl@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Mills-Peninsula Medical Center | Suspended |
Burlingame, California, United States, 94010 | |
Community Cancer Institute | Recruiting |
Clovis, California, United States, 93611 | |
Contact: Site Public Contact 559-387-1827 | |
Principal Investigator: Uzair B. Chaudhary | |
City of Hope Comprehensive Cancer Center | Active, not recruiting |
Duarte, California, United States, 91010 | |
Kaiser Permanente-Fontana | Recruiting |
Fontana, California, United States, 92335 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Helen H. Moon | |
Kaiser Permanente - Harbor City | Recruiting |
Harbor City, California, United States, 90710 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Helen H. Moon | |
Kaiser Permanente-Irvine | Recruiting |
Irvine, California, United States, 92618 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Helen H. Moon | |
UC San Diego Moores Cancer Center | Recruiting |
La Jolla, California, United States, 92093 | |
Contact: Site Public Contact 858-822-5354 cancercto@ucsd.edu | |
Principal Investigator: Rana R. McKay | |
Kaiser Permanente Los Angeles Medical Center | Recruiting |
Los Angeles, California, United States, 90027 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Helen H. Moon | |
USC / Norris Comprehensive Cancer Center | Active, not recruiting |
Los Angeles, California, United States, 90033 | |
Kaiser Permanente-Cadillac | Recruiting |
Los Angeles, California, United States, 90034 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Helen H. Moon | |
Cedars Sinai Medical Center | Recruiting |
Los Angeles, California, United States, 90048 | |
Contact: Site Public Contact 310-423-8965 | |
Principal Investigator: Timothy J. Daskivich | |
UCLA / Jonsson Comprehensive Cancer Center | Recruiting |
Los Angeles, California, United States, 90095 | |
Contact: Site Public Contact 888-798-0719 | |
Principal Investigator: Brian Shuch | |
Fremont - Rideout Cancer Center | Recruiting |
Marysville, California, United States, 95901 | |
Contact: Site Public Contact 530-749-4400 | |
Principal Investigator: Primo N. Lara | |
Palo Alto Medical Foundation-Camino Division | Suspended |
Mountain View, California, United States, 94040 | |
Kaiser Permanente-Oakland | Recruiting |
Oakland, California, United States, 94611 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Ontario | Recruiting |
Ontario, California, United States, 91761 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Helen H. Moon | |
UC Irvine Health/Chao Family Comprehensive Cancer Center | Recruiting |
Orange, California, United States, 92868 | |
Contact: Site Public Contact 877-827-8839 ucstudy@uci.edu | |
Principal Investigator: Nataliya Mar | |
Palo Alto Medical Foundation Health Care | Recruiting |
Palo Alto, California, United States, 94301 | |
Contact: Site Public Contact 415-209-2686 bernicl@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Stanford Cancer Institute Palo Alto | Recruiting |
Palo Alto, California, United States, 94304 | |
Contact: Site Public Contact 650-498-7061 ccto-office@stanford.edu | |
Principal Investigator: Sandy Srinivas | |
VA Palo Alto Health Care System | Recruiting |
Palo Alto, California, United States, 94304 | |
Contact: Site Public Contact 800-455-0057 | |
Principal Investigator: Brian Dietrich | |
Kaiser Permanente - Panorama City | Recruiting |
Panorama City, California, United States, 91402 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Helen H. Moon | |
Eisenhower Medical Center | Active, not recruiting |
Rancho Mirage, California, United States, 92270 | |
Kaiser Permanente-Riverside | Recruiting |
Riverside, California, United States, 92505 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Helen H. Moon | |
Kaiser Permanente-Roseville | Recruiting |
Roseville, California, United States, 95661 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Sutter Roseville Medical Center | Suspended |
Roseville, California, United States, 95661 | |
Kaiser Permanente Downtown Commons | Recruiting |
Sacramento, California, United States, 95814 | |
Contact: Site Public Contact 877-642-4691 kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Sutter Medical Center Sacramento | Suspended |
Sacramento, California, United States, 95816 | |
University of California Davis Comprehensive Cancer Center | Recruiting |
Sacramento, California, United States, 95817 | |
Contact: Site Public Contact 916-734-3089 | |
Principal Investigator: Primo N. Lara | |
Kaiser Permanente - Sacramento | Suspended |
Sacramento, California, United States, 95825 | |
Kaiser Permanente-San Diego Zion | Recruiting |
San Diego, California, United States, 92120 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Helen H. Moon | |
California Pacific Medical Center-Pacific Campus | Recruiting |
San Francisco, California, United States, 94115 | |
Contact: Site Public Contact 415-209-2686 bernicl@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Kaiser Permanente-San Francisco | Recruiting |
San Francisco, California, United States, 94115 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Santa Teresa-San Jose | Recruiting |
San Jose, California, United States, 95119 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente San Leandro | Recruiting |
San Leandro, California, United States, 94577 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Pacific Central Coast Health Center-San Luis Obispo | Suspended |
San Luis Obispo, California, United States, 93401 | |
Kaiser Permanente-San Marcos | Recruiting |
San Marcos, California, United States, 92078 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Helen H. Moon | |
Kaiser Permanente Medical Center - Santa Clara | Recruiting |
Santa Clara, California, United States, 95051 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Palo Alto Medical Foundation-Santa Cruz | Recruiting |
Santa Cruz, California, United States, 95065 | |
Contact: Site Public Contact 415-209-2686 bernicl@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Kaiser Permanente-South San Francisco | Recruiting |
South San Francisco, California, United States, 94080 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Palo Alto Medical Foundation-Sunnyvale | Recruiting |
Sunnyvale, California, United States, 94086 | |
Contact: Site Public Contact 415-209-2686 bernicl@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Gene Upshaw Memorial Tahoe Forest Cancer Center | Recruiting |
Truckee, California, United States, 96161 | |
Contact: Site Public Contact 530-582-6450 | |
Principal Investigator: Primo N. Lara | |
Kaiser Permanente-Vallejo | Recruiting |
Vallejo, California, United States, 94589 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Sutter Solano Medical Center/Cancer Center | Recruiting |
Vallejo, California, United States, 94589 | |
Contact: Site Public Contact 415-209-2686 bernicl@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Kaiser Permanente-Walnut Creek | Recruiting |
Walnut Creek, California, United States, 94596 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Presbyterian Intercommunity Hospital | Recruiting |
Whittier, California, United States, 90602 | |
Contact: Site Public Contact 562-698-0811 | |
Principal Investigator: Lisa S. Wang | |
Kaiser Permanente-Woodland Hills | Recruiting |
Woodland Hills, California, United States, 91367 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Helen H. Moon | |
United States, Colorado | |
University of Colorado Hospital | Recruiting |
Aurora, Colorado, United States, 80045 | |
Contact: Site Public Contact 720-848-0650 | |
Principal Investigator: Elaine T. Lam | |
UCHealth Memorial Hospital Central | Active, not recruiting |
Colorado Springs, Colorado, United States, 80909 | |
Memorial Hospital North | Active, not recruiting |
Colorado Springs, Colorado, United States, 80920 | |
Poudre Valley Hospital | Active, not recruiting |
Fort Collins, Colorado, United States, 80524 | |
Cancer Care and Hematology-Fort Collins | Active, not recruiting |
Fort Collins, Colorado, United States, 80528 | |
UCHealth Greeley Hospital | Active, not recruiting |
Greeley, Colorado, United States, 80631 | |
Medical Center of the Rockies | Active, not recruiting |
Loveland, Colorado, United States, 80538 | |
United States, Connecticut | |
Hartford Hospital | Suspended |
Hartford, Connecticut, United States, 06102 | |
Midstate Medical Center | Suspended |
Meriden, Connecticut, United States, 06451 | |
The Hospital of Central Connecticut | Recruiting |
New Britain, Connecticut, United States, 06050 | |
Contact: Site Public Contact 860-224-5660 | |
Principal Investigator: Jeffrey M. Kamradt | |
Yale University | Recruiting |
New Haven, Connecticut, United States, 06520 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: Michael E. Hurwitz | |
Eastern Connecticut Hematology and Oncology Associates | Recruiting |
Norwich, Connecticut, United States, 06360 | |
Contact: Site Public Contact 860-886-8362 | |
Principal Investigator: Dennis E. Slater | |
United States, District of Columbia | |
MedStar Washington Hospital Center | Recruiting |
Washington, District of Columbia, United States, 20010 | |
Contact: Site Public Contact 202-877-8839 | |
Principal Investigator: Ross E. Krasnow | |
Sibley Memorial Hospital | Recruiting |
Washington, District of Columbia, United States, 20016 | |
Contact: Site Public Contact 202-243-2373 jquiver1@jhmi.edu | |
Principal Investigator: Michael A. Carducci | |
George Washington University Medical Center | Recruiting |
Washington, District of Columbia, United States, 20037 | |
Contact: Site Public Contact 202-741-2981 | |
Principal Investigator: Jianqing Lin | |
United States, Florida | |
UM Sylvester Comprehensive Cancer Center at Coral Gables | Recruiting |
Coral Gables, Florida, United States, 33146 | |
Contact: Site Public Contact 305-243-2647 | |
Principal Investigator: Bruno Nahar Aragao de Oliveira | |
UM Sylvester Comprehensive Cancer Center at Deerfield Beach | Recruiting |
Deerfield Beach, Florida, United States, 33442 | |
Contact: Site Public Contact 305-243-2647 | |
Principal Investigator: Bruno Nahar Aragao de Oliveira | |
Holy Cross Hospital | Recruiting |
Fort Lauderdale, Florida, United States, 33308 | |
Contact: Site Public Contact 954-267-7750 | |
Principal Investigator: Philip J. Stella | |
University of Florida Health Science Center - Gainesville | Recruiting |
Gainesville, Florida, United States, 32610 | |
Contact: Site Public Contact 352-273-8010 cancer-center@ufl.edu | |
Principal Investigator: Jonathan A. Chatzkel | |
Baptist MD Anderson Cancer Center | Active, not recruiting |
Jacksonville, Florida, United States, 32207 | |
Lakeland Regional Health Hollis Cancer Center | Recruiting |
Lakeland, Florida, United States, 33805 | |
Contact: Site Public Contact 863-904-1900 | |
Principal Investigator: Peter Hinds | |
The Watson Clinic | Recruiting |
Lakeland, Florida, United States, 33805 | |
Contact: Site Public Contact 863-680-7780 | |
Principal Investigator: Leonard J. Gitter | |
University of Miami Miller School of Medicine-Sylvester Cancer Center | Recruiting |
Miami, Florida, United States, 33136 | |
Contact: Site Public Contact 305-243-2647 | |
Principal Investigator: Bruno Nahar Aragao de Oliveira | |
Miami Cancer Institute | Active, not recruiting |
Miami, Florida, United States, 33176 | |
UM Sylvester Comprehensive Cancer Center at Kendall | Recruiting |
Miami, Florida, United States, 33176 | |
Contact: Site Public Contact 305-243-2647 | |
Principal Investigator: Bruno Nahar Aragao de Oliveira | |
United States, Georgia | |
Emory University Hospital/Winship Cancer Institute | Recruiting |
Atlanta, Georgia, United States, 30322 | |
Contact: Site Public Contact 404-778-1868 | |
Principal Investigator: Viraj Master | |
Atlanta VA Medical Center | Recruiting |
Decatur, Georgia, United States, 30033 | |
Contact: Site Public Contact 404-321-6111 ext 7632 | |
Principal Investigator: Wayne B. Harris | |
United States, Hawaii | |
Hawaii Cancer Care - Savio | Suspended |
'Aiea, Hawaii, United States, 96701 | |
Pali Momi Medical Center | Recruiting |
'Aiea, Hawaii, United States, 96701 | |
Contact: Site Public Contact 808-486-6000 | |
Principal Investigator: Charles O. Kim | |
Hawaii Cancer Care Inc - Waterfront Plaza | Suspended |
Honolulu, Hawaii, United States, 96813 | |
Queen's Cancer Cenrer - POB I | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-532-0315 | |
Principal Investigator: Charles O. Kim | |
Queen's Medical Center | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-545-8548 | |
Principal Investigator: Charles O. Kim | |
Straub Clinic and Hospital | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-522-4333 | |
Principal Investigator: Charles O. Kim | |
Queen's Cancer Center - Kuakini | Recruiting |
Honolulu, Hawaii, United States, 96817 | |
Contact: Site Public Contact 808-531-8521 | |
Principal Investigator: Charles O. Kim | |
United States, Idaho | |
Saint Luke's Cancer Institute - Boise | Recruiting |
Boise, Idaho, United States, 83712 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Kootenai Medical Center | Recruiting |
Coeur d'Alene, Idaho, United States, 83814 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Fruitland | Recruiting |
Fruitland, Idaho, United States, 83619 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Saint Luke's Cancer Institute - Meridian | Recruiting |
Meridian, Idaho, United States, 83642 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Saint Luke's Cancer Institute - Nampa | Recruiting |
Nampa, Idaho, United States, 83686 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Kootenai Cancer Center | Recruiting |
Post Falls, Idaho, United States, 83854 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Kootenai Cancer Clinic | Recruiting |
Sandpoint, Idaho, United States, 83864 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Twin Falls | Recruiting |
Twin Falls, Idaho, United States, 83301 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
United States, Illinois | |
Illinois CancerCare-Bloomington | Recruiting |
Bloomington, Illinois, United States, 61704 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Canton | Recruiting |
Canton, Illinois, United States, 61520 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Carthage | Recruiting |
Carthage, Illinois, United States, 62321 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Northwestern University | Recruiting |
Chicago, Illinois, United States, 60611 | |
Contact: Site Public Contact 312-695-1301 cancer@northwestern.edu | |
Principal Investigator: Jeffrey A. Sosman | |
Rush University Medical Center | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-942-5498 clinical_trials@rush.edu | |
Principal Investigator: Timothy M. Kuzel | |
University of Illinois | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-355-3046 | |
Principal Investigator: Daniel Moreira | |
University of Chicago Comprehensive Cancer Center | Recruiting |
Chicago, Illinois, United States, 60637 | |
Contact: Site Public Contact 773-702-8222 cancerclinicaltrials@bsd.uchicago.edu | |
Principal Investigator: Walter M. Stadler | |
Carle on Vermilion | Recruiting |
Danville, Illinois, United States, 61832 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Vamsi K. Vasireddy | |
Cancer Care Specialists of Illinois - Decatur | Recruiting |
Decatur, Illinois, United States, 62526 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Carle Physician Group-Effingham | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Vamsi K. Vasireddy | |
Crossroads Cancer Center | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Elmhurst Memorial Hospital | Recruiting |
Elmhurst, Illinois, United States, 60126 | |
Contact: Site Public Contact 630-758-5460 Jrohde@emhc.org | |
Principal Investigator: Brian C. Myre | |
Illinois CancerCare-Eureka | Recruiting |
Eureka, Illinois, United States, 61530 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Galesburg | Recruiting |
Galesburg, Illinois, United States, 61401 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Northwestern Medicine Cancer Center Delnor | Suspended |
Geneva, Illinois, United States, 60134 | |
Edward Hines Jr VA Hospital | Recruiting |
Hines, Illinois, United States, 60141 | |
Contact: Site Public Contact 708-202-8387 | |
Principal Investigator: Elizabeth Henry | |
Illinois CancerCare-Kewanee Clinic | Recruiting |
Kewanee, Illinois, United States, 61443 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Macomb | Recruiting |
Macomb, Illinois, United States, 61455 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Carle Physician Group-Mattoon/Charleston | Recruiting |
Mattoon, Illinois, United States, 61938 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Vamsi K. Vasireddy | |
Loyola University Medical Center | Recruiting |
Maywood, Illinois, United States, 60153 | |
Contact: Site Public Contact 708-226-4357 | |
Principal Investigator: Stephanie A. Berg | |
Edward Hospital/Cancer Center | Recruiting |
Naperville, Illinois, United States, 60540 | |
Contact: Site Public Contact 630-646-6075 | |
Principal Investigator: Brian C. Myre | |
Cancer Care Center of O'Fallon | Recruiting |
O'Fallon, Illinois, United States, 62269 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Ottawa Clinic | Recruiting |
Ottawa, Illinois, United States, 61350 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Pekin | Recruiting |
Pekin, Illinois, United States, 61554 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Peoria | Recruiting |
Peoria, Illinois, United States, 61615 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Peru | Recruiting |
Peru, Illinois, United States, 61354 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Edward Hospital/Cancer Center?Plainfield | Recruiting |
Plainfield, Illinois, United States, 60585 | |
Contact: Site Public Contact 630-646-6075 Cancerresearch@edward.org | |
Principal Investigator: Brian C. Myre | |
Illinois CancerCare-Princeton | Recruiting |
Princeton, Illinois, United States, 61356 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Springfield Clinic | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 800-444-7541 | |
Principal Investigator: Bryan A. Faller | |
Carle Cancer Center | Recruiting |
Urbana, Illinois, United States, 61801 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Vamsi K. Vasireddy | |
The Carle Foundation Hospital | Recruiting |
Urbana, Illinois, United States, 61801 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Vamsi K. Vasireddy | |
Northwestern Medicine Cancer Center Warrenville | Recruiting |
Warrenville, Illinois, United States, 60555 | |
Contact: Site Public Contact 630-352-5360 Donald.Smith3@nm.org | |
Principal Investigator: Michael Kahn | |
United States, Indiana | |
Parkview Regional Medical Center | Recruiting |
Fort Wayne, Indiana, United States, 46845 | |
Contact: Site Public Contact 877-784-4673 | |
Principal Investigator: Zhentao Zhang | |
Indiana University/Melvin and Bren Simon Cancer Center | Recruiting |
Indianapolis, Indiana, United States, 46202 | |
Contact: Site Public Contact 317-278-5632 iutrials@iu.edu | |
Principal Investigator: Nabil Adra | |
Sidney and Lois Eskenazi Hospital | Recruiting |
Indianapolis, Indiana, United States, 46202 | |
Contact: Site Public Contact 317-278-5632 iutrials@iu.edu | |
Principal Investigator: Nabil Adra | |
Franciscan Health Indianapolis | Recruiting |
Indianapolis, Indiana, United States, 46237 | |
Contact: Site Public Contact 317-528-7060 | |
Principal Investigator: Naveed A. Rana | |
Woodland Cancer Care Center | Suspended |
Michigan City, Indiana, United States, 46360 | |
Franciscan Health Mooresville | Suspended |
Mooresville, Indiana, United States, 46158 | |
Reid Health | Recruiting |
Richmond, Indiana, United States, 47374 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
United States, Iowa | |
Mary Greeley Medical Center | Recruiting |
Ames, Iowa, United States, 50010 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC - Ames | Recruiting |
Ames, Iowa, United States, 50010 | |
Contact: Site Public Contact 515-239-4734 ksoder@mcfarlandclinic.com | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC-Boone | Recruiting |
Boone, Iowa, United States, 50036 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
Medical Oncology and Hematology Associates-West Des Moines | Recruiting |
Clive, Iowa, United States, 50325 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Cancer Center-West Lakes | Recruiting |
Clive, Iowa, United States, 50325 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Medical Oncology and Hematology Associates-Laurel | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Medical Center - Des Moines | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
McFarland Clinic PC-Trinity Cancer Center | Recruiting |
Fort Dodge, Iowa, United States, 50501 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC-Jefferson | Recruiting |
Jefferson, Iowa, United States, 50129 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC-Marshalltown | Recruiting |
Marshalltown, Iowa, United States, 50158 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
Mercy Medical Center-West Lakes | Recruiting |
West Des Moines, Iowa, United States, 50266 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Kansas | |
HaysMed University of Kansas Health System | Recruiting |
Hays, Kansas, United States, 67601 | |
Contact: Site Public Contact 785-623-5774 | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
University of Kansas Cancer Center | Recruiting |
Kansas City, Kansas, United States, 66160 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
Olathe Health Cancer Center | Recruiting |
Olathe, Kansas, United States, 66061 | |
Contact: Site Public Contact 913-355-8000 Jeni.wakefield@olathehealth.org | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
University of Kansas Cancer Center-Overland Park | Recruiting |
Overland Park, Kansas, United States, 66210 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
Ascension Via Christi - Pittsburg | Recruiting |
Pittsburg, Kansas, United States, 66762 | |
Contact: Site Public Contact 620-235-7900 jennifer.jameson@ascension.org | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
Salina Regional Health Center | Recruiting |
Salina, Kansas, United States, 67401 | |
Contact: Site Public Contact 785-452-7038 mleepers@srhc.com | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
Cotton O'Neil Cancer Center / Stormont Vail Health | Recruiting |
Topeka, Kansas, United States, 66606 | |
Contact: Site Public Contact 785-270-4939 | |
Principal Investigator: Mehmood H. Hashmi | |
University of Kansas Health System Saint Francis Campus | Recruiting |
Topeka, Kansas, United States, 66606 | |
Contact: Site Public Contact 785-295-8000 | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
University of Kansas Hospital-Westwood Cancer Center | Recruiting |
Westwood, Kansas, United States, 66205 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
United States, Kentucky | |
University of Kentucky/Markey Cancer Center | Recruiting |
Lexington, Kentucky, United States, 40536 | |
Contact: Site Public Contact 859-257-3379 | |
Principal Investigator: Peng Wang | |
United States, Louisiana | |
LSU Health Baton Rouge-North Clinic | Recruiting |
Baton Rouge, Louisiana, United States, 70805 | |
Contact: Site Public Contact 225-215-1353 clinicalresearch@marybird.com | |
Principal Investigator: David S. Hanson | |
Louisiana Hematology Oncology Associates LLC | Recruiting |
Baton Rouge, Louisiana, United States, 70809 | |
Contact: Site Public Contact 225-215-1353 clinicalresearch@marybird.com | |
Principal Investigator: David S. Hanson | |
Mary Bird Perkins Cancer Center | Recruiting |
Baton Rouge, Louisiana, United States, 70809 | |
Contact: Site Public Contact 225-215-1353 clinicalresearch@marybird.com | |
Principal Investigator: David S. Hanson | |
Our Lady of the Lake Physicians Group - Medical Oncology | Recruiting |
Baton Rouge, Louisiana, United States, 70809 | |
Contact: Site Public Contact 225-215-1353 clinicalresearch@marybird.com | |
Principal Investigator: David S. Hanson | |
Northshore Oncology Associates-Covington | Suspended |
Covington, Louisiana, United States, 70433 | |
Oncology Center of The South Incorporated | Suspended |
Houma, Louisiana, United States, 70360 | |
East Jefferson General Hospital | Recruiting |
Metairie, Louisiana, United States, 70006 | |
Contact: Site Public Contact 504-210-3539 emede1@lsuhsc.edu | |
Principal Investigator: Scott E. Delacroix | |
LSU Healthcare Network / Metairie Multi-Specialty Clinic | Recruiting |
Metairie, Louisiana, United States, 70006 | |
Contact: Site Public Contact 504-210-3539 emede1@lsuhsc.edu | |
Principal Investigator: Scott E. Delacroix | |
Louisiana State University Health Science Center | Suspended |
New Orleans, Louisiana, United States, 70112 | |
Tulane University Health Sciences Center | Recruiting |
New Orleans, Louisiana, United States, 70112 | |
Contact: Site Public Contact 504-988-6121 | |
Principal Investigator: Pedro M. Barata | |
University Medical Center New Orleans | Recruiting |
New Orleans, Louisiana, United States, 70112 | |
Contact: Site Public Contact 504-210-3539 emede1@lsuhsc.edu | |
Principal Investigator: Scott E. Delacroix | |
Ochsner Medical Center Jefferson | Active, not recruiting |
New Orleans, Louisiana, United States, 70121 | |
LSU Health Sciences Center at Shreveport | Active, not recruiting |
Shreveport, Louisiana, United States, 71103 | |
United States, Maine | |
Harold Alfond Center for Cancer Care | Recruiting |
Augusta, Maine, United States, 04330 | |
Contact: Site Public Contact 207-626-4855 | |
Principal Investigator: Peter Rubin | |
Eastern Maine Medical Center | Suspended |
Bangor, Maine, United States, 04401 | |
Waldo County General Hospital | Recruiting |
Belfast, Maine, United States, 04915 | |
Contact: Site Public Contact 207-338-2500 | |
Principal Investigator: Peter Rubin | |
MaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford | Recruiting |
Biddeford, Maine, United States, 04005 | |
Contact: Site Public Contact LLemire@mmc.org | |
Principal Investigator: Peter Rubin | |
Lafayette Family Cancer Center-EMMC | Recruiting |
Brewer, Maine, United States, 04412 | |
Contact: Site Public Contact 800-987-3005 | |
Principal Investigator: Sarah J. Sinclair | |
Penobscot Bay Medical Center | Recruiting |
Rockport, Maine, United States, 04856 | |
Contact: Site Public Contact 207-396-8670 ClinicalResearch@mmc.org | |
Principal Investigator: Peter Rubin | |
MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford | Recruiting |
Sanford, Maine, United States, 04073 | |
Contact: Site Public Contact LLemire@mmc.org | |
Principal Investigator: Peter Rubin | |
Maine Medical Partners - South Portland | Recruiting |
South Portland, Maine, United States, 04106 | |
Contact: Site Public Contact 207-396-8670 ClinicalResearch@mmc.org | |
Principal Investigator: Peter Rubin | |
United States, Maryland | |
Greater Baltimore Medical Center | Recruiting |
Baltimore, Maryland, United States, 21204 | |
Contact: Site Public Contact 443-849-3706 | |
Principal Investigator: Ari H. Elman | |
Johns Hopkins University/Sidney Kimmel Cancer Center | Recruiting |
Baltimore, Maryland, United States, 21287 | |
Contact: Site Public Contact 410-955-8804 jhcccro@jhmi.edu | |
Principal Investigator: Michael A. Carducci | |
United States, Massachusetts | |
Beverly Hospital | Recruiting |
Beverly, Massachusetts, United States, 01915 | |
Contact: Site Public Contact 978-922-3000 ext 2405 | |
Principal Investigator: Krishna S. Gunturu | |
Massachusetts General Hospital Cancer Center | Suspended |
Boston, Massachusetts, United States, 02114 | |
Brigham and Women's Hospital | Suspended |
Boston, Massachusetts, United States, 02115 | |
Boston Medical Center | Active, not recruiting |
Boston, Massachusetts, United States, 02118 | |
Beth Israel Deaconess Medical Center | Recruiting |
Boston, Massachusetts, United States, 02215 | |
Contact: Site Public Contact 617-667-9925 | |
Principal Investigator: Bradley A. McGregor | |
Dana-Farber Cancer Institute | Recruiting |
Boston, Massachusetts, United States, 02215 | |
Contact: Site Public Contact 877-442-3324 | |
Principal Investigator: Bradley A. McGregor | |
Lahey Hospital and Medical Center | Recruiting |
Burlington, Massachusetts, United States, 01805 | |
Contact: Site Public Contact 781-744-3421 cancerclinicaltrials@lahey.org | |
Principal Investigator: Krishna S. Gunturu | |
Simonds-Sinon Regional Cancer Center | Active, not recruiting |
Fitchburg, Massachusetts, United States, 01420 | |
Winchester Hospital | Recruiting |
Winchester, Massachusetts, United States, 01890 | |
Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com | |
Principal Investigator: Krishna S. Gunturu | |
UMass Memorial Medical Center - University Campus | Recruiting |
Worcester, Massachusetts, United States, 01655 | |
Contact: Site Public Contact 508-856-3216 cancer.research@umassmed.edu | |
Principal Investigator: Kriti Mittal | |
United States, Michigan | |
Saint Joseph Mercy Hospital | Recruiting |
Ann Arbor, Michigan, United States, 48106 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
University of Michigan Comprehensive Cancer Center | Recruiting |
Ann Arbor, Michigan, United States, 48109 | |
Contact: Site Public Contact 800-865-1125 | |
Principal Investigator: Ajjai S. Alva | |
Saint Joseph Mercy Brighton | Recruiting |
Brighton, Michigan, United States, 48114 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint Joseph Mercy Canton | Recruiting |
Canton, Michigan, United States, 48188 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint Joseph Mercy Chelsea | Recruiting |
Chelsea, Michigan, United States, 48118 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Wayne State University/Karmanos Cancer Institute | Recruiting |
Detroit, Michigan, United States, 48201 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Michael L. Cher | |
Henry Ford Hospital | Recruiting |
Detroit, Michigan, United States, 48202 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Ding Wang | |
Weisberg Cancer Treatment Center | Suspended |
Farmington Hills, Michigan, United States, 48334 | |
Spectrum Health at Butterworth Campus | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Sparrow Hospital | Recruiting |
Lansing, Michigan, United States, 48912 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Ascension Providence Hospitals - Novi | Recruiting |
Novi, Michigan, United States, 48374 | |
Contact: Site Public Contact 248-849-5332 karen.fife@ascension.org | |
Principal Investigator: Anibal Drelichman | |
William Beaumont Hospital-Royal Oak | Recruiting |
Royal Oak, Michigan, United States, 48073 | |
Contact: Site Public Contact 248-551-7695 | |
Principal Investigator: Sugandh D. Shetty | |
Ascension Providence Hospitals - Southfield | Recruiting |
Southfield, Michigan, United States, 48075 | |
Contact: Site Public Contact 248-849-5332 karen.fife@ascension.org | |
Principal Investigator: Anibal Drelichman | |
William Beaumont Hospital - Troy | Recruiting |
Troy, Michigan, United States, 48085 | |
Contact: Site Public Contact 248-551-7695 | |
Principal Investigator: Sugandh D. Shetty | |
United States, Minnesota | |
Abbott-Northwestern Hospital | Recruiting |
Minneapolis, Minnesota, United States, 55407 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Minneapolis VA Medical Center | Active, not recruiting |
Minneapolis, Minnesota, United States, 55417 | |
Mayo Clinic in Rochester | Recruiting |
Rochester, Minnesota, United States, 55905 | |
Contact: Site Public Contact 855-776-0015 | |
Principal Investigator: Brian A. Costello | |
Coborn Cancer Center at Saint Cloud Hospital | Recruiting |
Saint Cloud, Minnesota, United States, 56303 | |
Contact: Site Public Contact 877-229-4907 coborncancercenter@centracare.com | |
Principal Investigator: Donald J. Jurgens | |
United States, Mississippi | |
Gulfport Memorial Hospital | Recruiting |
Gulfport, Mississippi, United States, 39502 | |
Contact: Site Public Contact 504-210-3539 emede1@lsuhsc.edu | |
Principal Investigator: Scott E. Delacroix | |
University of Mississippi Medical Center | Recruiting |
Jackson, Mississippi, United States, 39216 | |
Contact: Site Public Contact 601-815-6700 | |
Principal Investigator: John C. Henegan | |
United States, Missouri | |
Saint Francis Medical Center | Recruiting |
Cape Girardeau, Missouri, United States, 63703 | |
Contact: Site Public Contact 573-334-2230 sfmc@sfmc.net | |
Principal Investigator: Bryan A. Faller | |
Saint Luke's Hospital | Recruiting |
Chesterfield, Missouri, United States, 63017 | |
Contact: Site Public Contact 314-205-6936 | |
Principal Investigator: Donald F. Busiek | |
University of Missouri - Ellis Fischel | Recruiting |
Columbia, Missouri, United States, 65212 | |
Contact: Site Public Contact 573-882-7440 | |
Principal Investigator: Katie S. Murray | |
Siteman Cancer Center at West County Hospital | Active, not recruiting |
Creve Coeur, Missouri, United States, 63141 | |
Truman Medical Centers | Recruiting |
Kansas City, Missouri, United States, 64108 | |
Contact: Site Public Contact 816-404-4375 | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
University of Kansas Cancer Center - North | Recruiting |
Kansas City, Missouri, United States, 64154 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
University of Kansas Cancer Center - Lee's Summit | Recruiting |
Lee's Summit, Missouri, United States, 64064 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
Washington University School of Medicine | Active, not recruiting |
Saint Louis, Missouri, United States, 63110 | |
Missouri Baptist Medical Center | Recruiting |
Saint Louis, Missouri, United States, 63131 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Saint Louis | Recruiting |
Saint Louis, Missouri, United States, 63141 | |
Contact: Site Public Contact 314-251-7066 | |
Principal Investigator: Jay W. Carlson | |
Siteman Cancer Center at Saint Peters Hospital | Active, not recruiting |
Saint Peters, Missouri, United States, 63376 | |
United States, Montana | |
Bozeman Deaconess Hospital | Recruiting |
Bozeman, Montana, United States, 59715 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Benefis Healthcare- Sletten Cancer Institute | Recruiting |
Great Falls, Montana, United States, 59405 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
United States, Nebraska | |
CHI Health Saint Francis | Recruiting |
Grand Island, Nebraska, United States, 68803 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Nebraska Methodist Hospital | Recruiting |
Omaha, Nebraska, United States, 68114 | |
Contact: Site Public Contact 402-354-5144 | |
Principal Investigator: Ralph J. Hauke | |
United States, Nevada | |
OptumCare Cancer Care at Seven Hills | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at Oakey | Recruiting |
Las Vegas, Nevada, United States, 89102 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada - Town Center | Recruiting |
Las Vegas, Nevada, United States, 89144 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at Fort Apache | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada - Central Valley | Recruiting |
Las Vegas, Nevada, United States, 89169 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
University Cancer Center | Suspended |
Las Vegas, Nevada, United States, 89169 | |
Renown Regional Medical Center | Recruiting |
Reno, Nevada, United States, 89502 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
United States, New Hampshire | |
Dartmouth Hitchcock Medical Center | Recruiting |
Lebanon, New Hampshire, United States, 03756 | |
Contact: Site Public Contact 800-639-6918 cancer.research.nurse@dartmouth.edu | |
Principal Investigator: Einar F. Sverrisson | |
United States, New Jersey | |
Englewood Hospital and Medical Center | Recruiting |
Englewood, New Jersey, United States, 07631 | |
Contact: Site Public Contact 201-894-3456 | |
Principal Investigator: Mazyar Ghanaat | |
Hackensack University Medical Center | Recruiting |
Hackensack, New Jersey, United States, 07601 | |
Contact: Site Public Contact 201-996-2879 | |
Principal Investigator: Robert S. Alter | |
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital | Suspended |
New Brunswick, New Jersey, United States, 08903 | |
Rutgers Cancer Institute of New Jersey | Recruiting |
New Brunswick, New Jersey, United States, 08903 | |
Contact: Site Public Contact 732-235-7356 | |
Principal Investigator: Eric A. Singer | |
Robert Wood Johnson University Hospital Somerset | Recruiting |
Somerville, New Jersey, United States, 08876 | |
Contact: Site Public Contact 908-685-2481 Siby.Varughese@rwjbh.org | |
Principal Investigator: Dhiren S. Dave | |
United States, New York | |
Albany Medical Center | Recruiting |
Albany, New York, United States, 12208 | |
Contact: Site Public Contact 518-262-5513 | |
Principal Investigator: Ronald P. Kaufman | |
Montefiore Medical Center-Einstein Campus | Recruiting |
Bronx, New York, United States, 10461 | |
Contact: Site Public Contact 718-379-6866 eskwak@montefiore.org | |
Principal Investigator: Benjamin A. Gartrell | |
Montefiore Medical Center-Weiler Hospital | Recruiting |
Bronx, New York, United States, 10461 | |
Contact: Site Public Contact 718-379-6866 eskwak@montefiore.org | |
Principal Investigator: Benjamin A. Gartrell | |
Montefiore Medical Center - Moses Campus | Recruiting |
Bronx, New York, United States, 10467 | |
Contact: Site Public Contact 718-379-6866 eskwak@montefiore.org | |
Principal Investigator: Benjamin A. Gartrell | |
James J Peters VA Medical Center | Suspended |
Bronx, New York, United States, 10468 | |
Glens Falls Hospital | Recruiting |
Glens Falls, New York, United States, 12801 | |
Contact: Site Public Contact 518-926-6700 | |
Principal Investigator: Scott D. Perrapato | |
Northwell Health/Center for Advanced Medicine | Recruiting |
Lake Success, New York, United States, 11042 | |
Contact: Site Public Contact 516-734-8896 | |
Principal Investigator: Thomas P. Bradley | |
Long Island Jewish Medical Center | Active, not recruiting |
New Hyde Park, New York, United States, 11040 | |
Laura and Isaac Perlmutter Cancer Center at NYU Langone | Recruiting |
New York, New York, United States, 10016 | |
Contact: Site Public Contact 212-263-4434 prmc.coordinator@nyumc.org | |
Principal Investigator: Arjun V. Balar | |
NYP/Weill Cornell Medical Center | Recruiting |
New York, New York, United States, 10065 | |
Contact: Site Public Contact 212-746-1848 | |
Principal Investigator: Ana M. Molina | |
University of Rochester | Recruiting |
Rochester, New York, United States, 14642 | |
Contact: Site Public Contact 585-275-5830 | |
Principal Investigator: Paul M. Barr | |
State University of New York Upstate Medical University | Recruiting |
Syracuse, New York, United States, 13210 | |
Contact: Site Public Contact 315-464-5476 | |
Principal Investigator: Gennady Bratslavsky | |
Dickstein Cancer Treatment Center | Recruiting |
White Plains, New York, United States, 10601 | |
Contact: Site Public Contact 914-849-7582 mcortese@wphospital.org | |
Principal Investigator: Dan Costin | |
United States, North Carolina | |
Rex Hematology Oncology Associates-Cary | Recruiting |
Cary, North Carolina, United States, 27518 | |
Contact: Site Public Contact 919-784-7209 | |
Principal Investigator: Rommel P. Lu | |
UNC Lineberger Comprehensive Cancer Center | Recruiting |
Chapel Hill, North Carolina, United States, 27599 | |
Contact: Site Public Contact 877-668-0683 cancerclinicaltrials@med.unc.edu | |
Principal Investigator: Tracy L. Rose | |
Southeastern Medical Oncology Center-Clinton | Active, not recruiting |
Clinton, North Carolina, United States, 28328 | |
Duke University Medical Center | Recruiting |
Durham, North Carolina, United States, 27710 | |
Contact: Site Public Contact 888-275-3853 | |
Principal Investigator: Jeffrey Crawford | |
Southeastern Medical Oncology Center-Goldsboro | Active, not recruiting |
Goldsboro, North Carolina, United States, 27534 | |
Wayne Memorial Hospital | Active, not recruiting |
Goldsboro, North Carolina, United States, 27534 | |
Onslow Memorial Hospital | Active, not recruiting |
Jacksonville, North Carolina, United States, 28546 | |
Southeastern Medical Oncology Center-Jacksonville | Active, not recruiting |
Jacksonville, North Carolina, United States, 28546 | |
Vidant Oncology-Kenansville | Recruiting |
Kenansville, North Carolina, United States, 28349 | |
Contact: Site Public Contact 252-559-2201 Carla.Zimmerman@vidanthealth.com | |
Principal Investigator: Misbah U. Qadir | |
Vidant Oncology-Kinston | Recruiting |
Kinston, North Carolina, United States, 28501 | |
Contact: Site Public Contact 252-559-2201 Carla.Zimmerman@vidanthealth.com | |
Principal Investigator: Misbah U. Qadir | |
Rex Cancer Center | Recruiting |
Raleigh, North Carolina, United States, 27607 | |
Contact: Site Public Contact 919-784-7209 | |
Principal Investigator: Rommel P. Lu | |
Rex Hematology Oncology Associates-Blue Ridge | Recruiting |
Raleigh, North Carolina, United States, 27607 | |
Contact: Site Public Contact 919-784-7209 | |
Principal Investigator: Rommel P. Lu | |
Rex Cancer Center of Wakefield | Recruiting |
Raleigh, North Carolina, United States, 27614 | |
Contact: Site Public Contact 919-784-7209 | |
Principal Investigator: Rommel P. Lu | |
Vidant Oncology-Richlands | Suspended |
Richlands, North Carolina, United States, 28574 | |
Wake Forest University Health Sciences | Recruiting |
Winston-Salem, North Carolina, United States, 27157 | |
Contact: Site Public Contact 336-713-6771 | |
Principal Investigator: Michael M. Goodman | |
United States, North Dakota | |
Sanford Bismarck Medical Center | Recruiting |
Bismarck, North Dakota, United States, 58501 | |
Contact: Site Public Contact 701-323-5760 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
Sanford Broadway Medical Center | Recruiting |
Fargo, North Dakota, United States, 58122 | |
Contact: Site Public Contact 701-323-5760 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
Sanford Roger Maris Cancer Center | Recruiting |
Fargo, North Dakota, United States, 58122 | |
Contact: Site Public Contact 701-234-6161 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
United States, Ohio | |
Dayton Physicians LLC-Miami Valley South | Recruiting |
Centerville, Ohio, United States, 45459 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
University of Cincinnati/Barrett Cancer Center | Recruiting |
Cincinnati, Ohio, United States, 45219 | |
Contact: Site Public Contact 513-558-4553 uchealthnews@uc.edu | |
Principal Investigator: Abhinav Sidana | |
Good Samaritan Hospital - Cincinnati | Recruiting |
Cincinnati, Ohio, United States, 45220 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Bethesda North Hospital | Suspended |
Cincinnati, Ohio, United States, 45242 | |
Case Western Reserve University | Recruiting |
Cleveland, Ohio, United States, 44106 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Prateek Mendiratta | |
MetroHealth Medical Center | Recruiting |
Cleveland, Ohio, United States, 44109 | |
Contact: Site Public Contact 216-778-8526 dstrater@metrohealth.org | |
Principal Investigator: William Tse | |
Dayton Physicians LLC-Atrium | Recruiting |
Franklin, Ohio, United States, 45005 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Kettering Medical Center | Recruiting |
Kettering, Ohio, United States, 45429 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
UH Seidman Cancer Center at Southwest General Hospital | Recruiting |
Middleburg Heights, Ohio, United States, 44130 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Prateek Mendiratta | |
Toledo Clinic Cancer Centers-Toledo | Recruiting |
Toledo, Ohio, United States, 43623 | |
Contact: Site Public Contact 800-444-3561 | |
Principal Investigator: Rex B. Mowat | |
University Pointe | Recruiting |
West Chester, Ohio, United States, 45069 | |
Contact: Site Public Contact clinicaltrials@ucphysicians.com | |
Principal Investigator: Abhinav Sidana | |
UH Seidman Cancer Center at Saint John Medical Center | Suspended |
Westlake, Ohio, United States, 44145 | |
United States, Oklahoma | |
University of Oklahoma Health Sciences Center | Recruiting |
Oklahoma City, Oklahoma, United States, 73104 | |
Contact: Site Public Contact 405-271-8777 ou-clinical-trials@ouhsc.edu | |
Principal Investigator: Brian W. Cross | |
Mercy Hospital Oklahoma City | Recruiting |
Oklahoma City, Oklahoma, United States, 73120 | |
Contact: Site Public Contact 405-752-3402 | |
Principal Investigator: Jay W. Carlson | |
United States, Oregon | |
Providence Cancer Institute Clackamas Clinic | Suspended |
Clackamas, Oregon, United States, 97015 | |
Rogue Valley Medical Center | Recruiting |
Medford, Oregon, United States, 97504 | |
Contact: Site Public Contact 541-789-6176 | |
Principal Investigator: Liam C. Macleod | |
Providence Newberg Medical Center | Suspended |
Newberg, Oregon, United States, 97132 | |
Providence Willamette Falls Medical Center | Suspended |
Oregon City, Oregon, United States, 97045 | |
Providence Portland Medical Center | Recruiting |
Portland, Oregon, United States, 97213 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Saint Vincent Medical Center | Suspended |
Portland, Oregon, United States, 97225 | |
Kaiser Permanente Northwest | Active, not recruiting |
Portland, Oregon, United States, 97227 | |
Oregon Health and Science University | Recruiting |
Portland, Oregon, United States, 97239 | |
Contact: Site Public Contact 503-494-1080 trials@ohsu.edu | |
Principal Investigator: Christopher W. Ryan | |
United States, Pennsylvania | |
Lehigh Valley Hospital-Cedar Crest | Recruiting |
Allentown, Pennsylvania, United States, 18103 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Lehigh Valley Hospital - Muhlenberg | Recruiting |
Bethlehem, Pennsylvania, United States, 18017 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Geisinger Medical Center | Recruiting |
Danville, Pennsylvania, United States, 17822 | |
Contact: Site Public Contact 570-271-5251 HemonCCTrials@geisinger.edu | |
Principal Investigator: Heinric Williams | |
Penn State Milton S Hershey Medical Center | Recruiting |
Hershey, Pennsylvania, United States, 17033-0850 | |
Contact: Site Public Contact 717-531-3779 CTO@hmc.psu.edu | |
Principal Investigator: Monika Joshi | |
University of Pennsylvania/Abramson Cancer Center | Recruiting |
Philadelphia, Pennsylvania, United States, 19104 | |
Contact: Site Public Contact 800-474-9892 | |
Principal Investigator: Vivek K. Narayan | |
Fox Chase Cancer Center | Recruiting |
Philadelphia, Pennsylvania, United States, 19111 | |
Contact: Site Public Contact 215-728-4790 | |
Principal Investigator: Pooja Ghatalia | |
Temple University Hospital | Suspended |
Philadelphia, Pennsylvania, United States, 19140 | |
University of Pittsburgh Cancer Institute (UPCI) | Recruiting |
Pittsburgh, Pennsylvania, United States, 15232 | |
Contact: Site Public Contact 412-647-8073 | |
Principal Investigator: Leonard J. Appleman | |
Reading Hospital | Recruiting |
West Reading, Pennsylvania, United States, 19611 | |
Contact: Site Public Contact 610-988-9323 | |
Principal Investigator: Terrence P. Cescon | |
UPMC Susquehanna | Recruiting |
Williamsport, Pennsylvania, United States, 17701 | |
Contact: Site Public Contact 800-598-4282 | |
Principal Investigator: Leonard J. Appleman | |
United States, Rhode Island | |
Rhode Island Hospital | Active, not recruiting |
Providence, Rhode Island, United States, 02903 | |
Miriam Hospital | Active, not recruiting |
Providence, Rhode Island, United States, 02906 | |
United States, South Carolina | |
Prisma Health Cancer Institute - Spartanburg | Recruiting |
Boiling Springs, South Carolina, United States, 29316 | |
Contact: Site Public Contact 864-522-2066 kim.williams3@prismahealth.org | |
Principal Investigator: Jeffrey K. Giguere | |
Ralph H Johnson VA Medical Center | Suspended |
Charleston, South Carolina, United States, 29401 | |
Medical University of South Carolina | Active, not recruiting |
Charleston, South Carolina, United States, 29425 | |
Prisma Health Cancer Institute - Laurens | Suspended |
Clinton, South Carolina, United States, 29325 | |
Prisma Health Cancer Institute - Easley | Recruiting |
Easley, South Carolina, United States, 29640 | |
Contact: Site Public Contact 864-522-2066 kim.williams3@prismahealth.org | |
Principal Investigator: Jeffrey K. Giguere | |
Gibbs Cancer Center-Gaffney | Recruiting |
Gaffney, South Carolina, United States, 29341 | |
Contact: Site Public Contact 864-560-6104 kmertz-rivera@gibbscc.org | |
Principal Investigator: Michael Humeniuk | |
Saint Francis Hospital | Recruiting |
Greenville, South Carolina, United States, 29601 | |
Contact: Site Public Contact 864-603-6213 melissa_beckman@bshsi.org | |
Principal Investigator: Robert D. Siegel | |
Prisma Health Cancer Institute - Butternut | Recruiting |
Greenville, South Carolina, United States, 29605 | |
Contact: Site Public Contact 864-522-2066 kim.williams3@prismahealth.org | |
Principal Investigator: Jeffrey K. Giguere | |
Prisma Health Cancer Institute - Faris | Recruiting |
Greenville, South Carolina, United States, 29605 | |
Contact: Site Public Contact 864-522-2066 kim.williams3@prismahealth.org | |
Principal Investigator: Jeffrey K. Giguere | |
Saint Francis Cancer Center | Recruiting |
Greenville, South Carolina, United States, 29607 | |
Contact: Site Public Contact 864-603-6213 melissa_beckman@bshsi.org | |
Principal Investigator: Robert D. Siegel | |
Prisma Health Cancer Institute - Eastside | Recruiting |
Greenville, South Carolina, United States, 29615 | |
Contact: Site Public Contact 864-522-2066 kim.williams3@prismahealth.org | |
Principal Investigator: Jeffrey K. Giguere | |
Prisma Health Cancer Institute - Greer | Recruiting |
Greer, South Carolina, United States, 29650 | |
Contact: Site Public Contact 864-522-2066 kim.williams3@prismahealth.org | |
Principal Investigator: Jeffrey K. Giguere | |
Gibbs Cancer Center-Pelham | Recruiting |
Greer, South Carolina, United States, 29651 | |
Contact: Site Public Contact 864-560-6104 kmertz-rivera@gibbscc.org | |
Principal Investigator: Michael Humeniuk | |
Prisma Health Cancer Institute - Seneca | Recruiting |
Seneca, South Carolina, United States, 29672 | |
Contact: Site Public Contact 864-522-2066 kim.williams3@prismahealth.org | |
Principal Investigator: Jeffrey K. Giguere | |
Spartanburg Medical Center | Recruiting |
Spartanburg, South Carolina, United States, 29303 | |
Contact: Site Public Contact 864-560-6104 kmertz-rivera@gibbscc.org | |
Principal Investigator: Michael Humeniuk | |
Lexington Medical Center | Recruiting |
West Columbia, South Carolina, United States, 29169 | |
Contact: Site Public Contact 803-791-2105 LMCIRB@lexhealth.org | |
Principal Investigator: Steven A. Madden | |
United States, Tennessee | |
Meharry Medical College | Active, not recruiting |
Nashville, Tennessee, United States, 37208 | |
Vanderbilt University/Ingram Cancer Center | Recruiting |
Nashville, Tennessee, United States, 37232 | |
Contact: Site Public Contact 800-811-8480 | |
Principal Investigator: Nancy B. Davis | |
United States, Texas | |
UT Southwestern/Simmons Cancer Center-Dallas | Recruiting |
Dallas, Texas, United States, 75390 | |
Contact: Site Public Contact 214-648-7097 canceranswerline@UTSouthwestern.edu | |
Principal Investigator: Vitaly Margulis | |
UT Southwestern/Simmons Cancer Center-Fort Worth | Recruiting |
Fort Worth, Texas, United States, 76104 | |
Contact: Site Public Contact 214-648-7097 canceranswerline@UTSouthwestern.edu | |
Principal Investigator: Vitaly Margulis | |
University of Texas Medical Branch | Active, not recruiting |
Galveston, Texas, United States, 77555-0565 | |
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Site Public Contact 713-798-1354 burton@bcm.edu | |
Principal Investigator: Aihua E. Yen | |
Ben Taub General Hospital | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Site Public Contact 713-873-2000 | |
Principal Investigator: Aihua E. Yen | |
UTMB Cancer Center at Victory Lakes | Active, not recruiting |
League City, Texas, United States, 77573 | |
UT Southwestern Clinical Center at Richardson/Plano | Recruiting |
Richardson, Texas, United States, 75080 | |
Contact: Site Public Contact 972-669-7044 Suzanne.cole@utsouthwestern.edu | |
Principal Investigator: Vitaly Margulis | |
Audie L Murphy VA Hospital | Recruiting |
San Antonio, Texas, United States, 78229 | |
Contact: Site Public Contact 877-469-5300 | |
Principal Investigator: Paromita Datta | |
University of Texas Health Science Center at San Antonio | Recruiting |
San Antonio, Texas, United States, 78229 | |
Contact: Site Public Contact 210-450-3800 phoresearchoffice@uthscsa.edu | |
Principal Investigator: Michael A. Liss | |
United States, Utah | |
Farmington Health Center | Recruiting |
Farmington, Utah, United States, 84025 | |
Contact: Site Public Contact 888-424-2100 cancerinfo@hci.utah.edu | |
Principal Investigator: Brock O'Neil | |
Huntsman Cancer Institute/University of Utah | Recruiting |
Salt Lake City, Utah, United States, 84112 | |
Contact: Site Public Contact 888-424-2100 cancerinfo@hci.utah.edu | |
Principal Investigator: Brock O'Neil | |
South Jordan Health Center | Suspended |
South Jordan, Utah, United States, 84009 | |
United States, Vermont | |
Central Vermont Medical Center/National Life Cancer Treatment | Recruiting |
Berlin, Vermont, United States, 05602 | |
Contact: Site Public Contact 802-225-5400 | |
Principal Investigator: Scott D. Perrapato | |
University of Vermont Medical Center | Recruiting |
Burlington, Vermont, United States, 05401 | |
Contact: Site Public Contact 802-656-4101 rpo@uvm.edu | |
Principal Investigator: Scott D. Perrapato | |
University of Vermont and State Agricultural College | Suspended |
Burlington, Vermont, United States, 05405 | |
United States, Virginia | |
University of Virginia Cancer Center | Recruiting |
Charlottesville, Virginia, United States, 22908 | |
Contact: Site Public Contact 434-243-6303 PAS9E@virginia.edu | |
Principal Investigator: Robert Dreicer | |
Sovah Health Martinsville | Recruiting |
Martinsville, Virginia, United States, 24115 | |
Contact: Site Public Contact 276-666-7489 sharon.hubbard@lpnt.net | |
Principal Investigator: Mohammed Saad | |
Bon Secours Memorial Regional Medical Center | Recruiting |
Mechanicsville, Virginia, United States, 23116 | |
Contact: Site Public Contact 804-893-8663 Jaime_scott@bshsi.org | |
Principal Investigator: William J. Irvin | |
Bon Secours Saint Francis Medical Center | Recruiting |
Midlothian, Virginia, United States, 23114 | |
Contact: Site Public Contact 804-893-8663 Jaime_scott@bshsi.org | |
Principal Investigator: William J. Irvin | |
Bon Secours Saint Mary's Hospital | Recruiting |
Richmond, Virginia, United States, 23226 | |
Contact: Site Public Contact 804-893-8663 Jaime_scott@bshsi.org | |
Principal Investigator: William J. Irvin | |
Virginia Commonwealth University/Massey Cancer Center | Recruiting |
Richmond, Virginia, United States, 23298 | |
Contact: Site Public Contact 804-628-1914 klcampbell@vcu.edu | |
Principal Investigator: Asit K. Paul | |
United States, Washington | |
Harrison HealthPartners Hematology and Oncology-Bremerton | Recruiting |
Bremerton, Washington, United States, 98310 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Kadlec Clinic Hematology and Oncology | Recruiting |
Kennewick, Washington, United States, 99336 | |
Contact: Site Public Contact 509-783-4637 research@kadlecmed.org | |
Principal Investigator: Alison K. Conlin | |
Fred Hutchinson Cancer Research Center | Recruiting |
Seattle, Washington, United States, 98109 | |
Contact: Site Public Contact 800-804-8824 | |
Principal Investigator: Sarah P. Psutka | |
Seattle Cancer Care Alliance | Recruiting |
Seattle, Washington, United States, 98109 | |
Contact: Site Public Contact 800-804-8824 | |
Principal Investigator: Sarah P. Psutka | |
University of Washington Medical Center - Montlake | Recruiting |
Seattle, Washington, United States, 98195 | |
Contact: Site Public Contact 800-804-8824 | |
Principal Investigator: Sarah P. Psutka | |
United States, Wisconsin | |
Langlade Hospital and Cancer Center | Recruiting |
Antigo, Wisconsin, United States, 54409 | |
Contact: Site Public Contact 715-623-9869 Juli.Alford@aspirus.org | |
Principal Investigator: Harish G. Ahuja | |
ThedaCare Regional Cancer Center | Recruiting |
Appleton, Wisconsin, United States, 54911 | |
Contact: Site Public Contact 920-364-3605 ResearchDept@thedacare.org | |
Principal Investigator: Harsha V. Poola | |
Ascension Southeast Wisconsin Hospital - Elmbrook Campus | Recruiting |
Brookfield, Wisconsin, United States, 53045 | |
Contact: Site Public Contact 414-635-6420 AWRI.Inquiry@Ascension.org | |
Principal Investigator: Jonathan S. Treisman | |
Aurora Cancer Care-Southern Lakes VLCC | Recruiting |
Burlington, Wisconsin, United States, 53105 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
Marshfield Medical Center-EC Cancer Center | Recruiting |
Eau Claire, Wisconsin, United States, 54701 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Demet Gokalp Yasar | |
Aurora Health Center-Fond du Lac | Recruiting |
Fond Du Lac, Wisconsin, United States, 54937 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
Ascension Saint Francis - Reiman Cancer Center | Recruiting |
Franklin, Wisconsin, United States, 53132 | |
Contact: Site Public Contact 414-635-6420 AWRI.Inquiry@Ascension.org | |
Principal Investigator: Jonathan S. Treisman | |
Aurora Health Care Germantown Health Center | Recruiting |
Germantown, Wisconsin, United States, 53022 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
Aurora Cancer Care-Grafton | Recruiting |
Grafton, Wisconsin, United States, 53024 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
Aurora BayCare Medical Center | Recruiting |
Green Bay, Wisconsin, United States, 54311 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
UW Cancer Center Johnson Creek | Recruiting |
Johnson Creek, Wisconsin, United States, 53038 | |
Contact: Site Public Contact 920-699-3500 lynda.persico@uwmf.wisc.edu | |
Principal Investigator: Hamid Emamekhoo | |
Aurora Cancer Care-Kenosha South | Recruiting |
Kenosha, Wisconsin, United States, 53142 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
William S Middleton VA Medical Center | Recruiting |
Madison, Wisconsin, United States, 53705 | |
Contact: Site Public Contact 608-256-1901 ext 17007 | |
Principal Investigator: David Kosoff | |
University of Wisconsin Hospital and Clinics | Recruiting |
Madison, Wisconsin, United States, 53792 | |
Contact: Site Public Contact 800-622-8922 | |
Principal Investigator: Hamid Emamekhoo | |
Aurora Bay Area Medical Group-Marinette | Recruiting |
Marinette, Wisconsin, United States, 54143 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
Marshfield Medical Center-Marshfield | Suspended |
Marshfield, Wisconsin, United States, 54449 | |
Aspirus Medford Hospital | Recruiting |
Medford, Wisconsin, United States, 54451 | |
Contact: Site Public Contact 715-847-2353 Beth.Knetter@aspirus.org | |
Principal Investigator: Harish G. Ahuja | |
Aurora Cancer Care-Milwaukee | Recruiting |
Milwaukee, Wisconsin, United States, 53209 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
Aurora Saint Luke's Medical Center | Recruiting |
Milwaukee, Wisconsin, United States, 53215 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
Medical College of Wisconsin | Recruiting |
Milwaukee, Wisconsin, United States, 53226 | |
Contact: Site Public Contact 414-805-3666 | |
Principal Investigator: Deepak Kilari | |
Aurora Sinai Medical Center | Recruiting |
Milwaukee, Wisconsin, United States, 53233 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
Marshfield Clinic-Minocqua Center | Recruiting |
Minocqua, Wisconsin, United States, 54548 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Demet Gokalp Yasar | |
ProHealth D N Greenwald Center | Suspended |
Mukwonago, Wisconsin, United States, 53149 | |
ProHealth Oconomowoc Memorial Hospital | Suspended |
Oconomowoc, Wisconsin, United States, 53066 | |
Vince Lombardi Cancer Clinic - Oshkosh | Recruiting |
Oshkosh, Wisconsin, United States, 54904 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
Aurora Cancer Care-Racine | Recruiting |
Racine, Wisconsin, United States, 53406 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
Marshfield Medical Center-Rice Lake | Recruiting |
Rice Lake, Wisconsin, United States, 54868 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Demet Gokalp Yasar | |
Vince Lombardi Cancer Clinic-Sheboygan | Recruiting |
Sheboygan, Wisconsin, United States, 53081 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
Marshfield Clinic Stevens Point Center | Recruiting |
Stevens Point, Wisconsin, United States, 54482 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Demet Gokalp Yasar | |
Aurora Medical Center in Summit | Recruiting |
Summit, Wisconsin, United States, 53066 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
Vince Lombardi Cancer Clinic-Two Rivers | Recruiting |
Two Rivers, Wisconsin, United States, 54241 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
ProHealth Waukesha Memorial Hospital | Suspended |
Waukesha, Wisconsin, United States, 53188 | |
UW Cancer Center at ProHealth Care | Suspended |
Waukesha, Wisconsin, United States, 53188 | |
Aspirus Regional Cancer Center | Recruiting |
Wausau, Wisconsin, United States, 54401 | |
Contact: Site Public Contact 877-405-6866 | |
Principal Investigator: Harish G. Ahuja | |
Marshfield Clinic-Wausau Center | Recruiting |
Wausau, Wisconsin, United States, 54401 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Demet Gokalp Yasar | |
Ascension Medical Group Southeast Wisconsin - Mayfair Road | Recruiting |
Wauwatosa, Wisconsin, United States, 53226 | |
Contact: Site Public Contact 414-635-6420 AWRI.Inquiry@Ascension.org | |
Principal Investigator: Jonathan S. Treisman | |
Aurora Cancer Care-Milwaukee West | Recruiting |
Wauwatosa, Wisconsin, United States, 53226 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
Aurora West Allis Medical Center | Recruiting |
West Allis, Wisconsin, United States, 53227 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Antony Ruggeri | |
Marshfield Medical Center - Weston | Recruiting |
Weston, Wisconsin, United States, 54476 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Demet Gokalp Yasar | |
Aspirus Cancer Care - Wisconsin Rapids | Recruiting |
Wisconsin Rapids, Wisconsin, United States, 54494 | |
Contact: Site Public Contact 715-422-7718 | |
Principal Investigator: Harish G. Ahuja | |
Canada, Alberta | |
Tom Baker Cancer Centre | Recruiting |
Calgary, Alberta, Canada, T2N 4N2 | |
Contact: Site Public Contact 403-521-3433 | |
Principal Investigator: Daniel Y. Heng | |
Cross Cancer Institute | Suspended |
Edmonton, Alberta, Canada, T6G 1Z2 | |
Canada, Manitoba | |
CancerCare Manitoba | Suspended |
Winnipeg, Manitoba, Canada, R3E 0V9 | |
Canada, New Brunswick | |
The Moncton Hospital | Suspended |
Moncton, New Brunswick, Canada, E1C 6Z8 | |
Canada, Nova Scotia | |
QEII Health Sciences Centre/Nova Scotia Health Authority | Recruiting |
Halifax, Nova Scotia, Canada, B3H 2Y9 | |
Contact: Site Public Contact 902-473-6000 | |
Principal Investigator: Lori A. Wood | |
Canada, Ontario | |
Saint Joseph's Healthcare Charlton Campus | Recruiting |
Hamilton, Ontario, Canada, L8N 4A6 | |
Contact: Site Public Contact 905-522-1155 ext 36115 research@stjoes.ca | |
Principal Investigator: Anil Kapoor | |
Juravinski Cancer Centre at Hamilton Health Sciences | Recruiting |
Hamilton, Ontario, Canada, L8V 5C2 | |
Contact: Site Public Contact 905-387-9495 | |
Principal Investigator: Sebastien J. Hotte | |
Kingston Health Sciences Centre | Recruiting |
Kingston, Ontario, Canada, K7L 2V7 | |
Contact: Site Public Contact 613-549-6666 cc-clinicaltrials@kgh.kari.net | |
Principal Investigator: Francisco E. Vera Badillo | |
London Regional Cancer Program | Recruiting |
London, Ontario, Canada, N6A 4L6 | |
Contact: Site Public Contact 519-685-8600 | |
Principal Investigator: Nicholas E. Power | |
Niagara Health System-Saint Catharines General | Recruiting |
Saint Catharines, Ontario, Canada, L2S 0A9 | |
Contact: Site Public Contact 905-682-6451 | |
Principal Investigator: Michael A. Levesque | |
Odette Cancer Centre- Sunnybrook Health Sciences Centre | Suspended |
Toronto, Ontario, Canada, M4N 3M5 | |
University Health Network-Princess Margaret Hospital | Recruiting |
Toronto, Ontario, Canada, M5G 2M9 | |
Contact: Site Public Contact 416-946-4501 clinical.trials@uhn.on.ca | |
Principal Investigator: Antonio Finelli | |
Windsor Regional Cancer Centre | Suspended |
Windsor, Ontario, Canada, N8W 2X3 | |
Canada, Quebec | |
CHUM - Centre Hospitalier de l'Universite de Montreal | Recruiting |
Montreal, Quebec, Canada, H2X 3E4 | |
Contact: Site Public Contact 514-890-8000 ext 12725 info.cr.chum@ssss.gouv.qc.ca | |
Principal Investigator: Jean-Baptiste Lattouf | |
Centre Hospitalier Universitaire de Sherbrooke-Fleurimont | Recruiting |
Sherbrooke, Quebec, Canada, J1H 5N4 | |
Contact: Site Public Contact 819-820-6480 crcinformation.chus@ssss.gouv.qc.ca | |
Principal Investigator: Michel Pavic | |
Israel | |
Rambam Medical Center | Recruiting |
Haifa, Israel, 31096 | |
Contact: Site Public Contact 972-4-8541737 y_rozen@rambam.health.gov.il | |
Principal Investigator: Avivit Peer | |
Shaare Zedek Medical Center | Suspended |
Jerusalem, Israel, 91031 |
Principal Investigator: | Lauren Harshman | ECOG-ACRIN Cancer Research Group |
Responsible Party: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT03055013 |
Other Study ID Numbers: |
NCI-2016-00326 NCI-2016-00326 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) ) EA8143 EA8143 ( Other Identifier: ECOG-ACRIN Cancer Research Group ) EA8143 ( Other Identifier: CTEP ) U10CA180820 ( U.S. NIH Grant/Contract ) |
First Posted: | February 16, 2017 Key Record Dates |
Last Update Posted: | March 3, 2021 |
Last Verified: | November 2020 |
Studies a U.S. FDA-regulated Drug Product: | Yes |
Studies a U.S. FDA-regulated Device Product: | No |
Carcinoma Carcinoma, Renal Cell Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Adenocarcinoma Kidney Neoplasms Urologic Neoplasms |
Urogenital Neoplasms Neoplasms by Site Kidney Diseases Urologic Diseases Nivolumab Antineoplastic Agents, Immunological Antineoplastic Agents |